Kite Pharma Takes Cue From Battle Between Gilead (GILD), AbbVie (ABBV)

January 16, 2015 9:55 PM

13 0

In the aftermath of the recent battle between Gilead Sciences and AbbVie, Kite Pharma has started discussions with insurers to convince them to cover its experimental cancer treatment

Kite Pharma Inc, has recently started discussions with the insurers to convince them to cover the experimental cancer treatment being developed by the company – which is expected to cost hundreds of thousands of dollars – given that the treatment meets its endpoints in trials, and ultimately gets th...

Read more

To category page